These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8139147)

  • 21. Urinary fibrinogen degradation products and differential protein clearances in renal disease.
    Blainey JD; Terry JM
    Clin Nephrol; 1979 Mar; 11(3):140-1. PubMed ID: 436342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary platelet factor four (Pf4) levels in mesangial IgA glomerulonephritis and thin basement membrane disease.
    Taira K; Hewitson TD; Kincaid-Smith P
    Clin Nephrol; 1992 Jan; 37(1):8-13. PubMed ID: 1541068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary fibrin (-ogen) degradation products in Russell's viper (Daboia russelii siamensis) bite victims.
    Han KE; Than T; Lwin M; Swe TN; Pe T
    Southeast Asian J Trop Med Public Health; 1993 Mar; 24(1):198-201. PubMed ID: 8362297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis].
    Imoto K; Yasumuro Y; Taki M; Suzuki N; Tanabe H; Ichikawa Y
    Rinsho Byori; 2001 Mar; 49(3):283-9. PubMed ID: 11307330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibrinogen degradation products in acute renal failure of the newborn.
    Assadi F; Delivoria-Papadopoulos M; Pereira G; Peckham G; Norman M
    Clin Nephrol; 1983 Feb; 19(2):74-81. PubMed ID: 6839555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical significance of urinary fibrinogen degradation products in renal disease: study with two methods and correlation with histological findings of intraglomerular coagulation.
    Loschiavo C; Previato G; Valvo E; Lupo A; Tessitore N; Chiaramonte S; Maschio G
    Nephron; 1981; 28(4):200-3. PubMed ID: 7029322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy.
    Shimoike T; Inoguchi T; Umeda F; Nawata H; Kawano K; Ochi H
    Metabolism; 2000 Aug; 49(8):1030-5. PubMed ID: 10954022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary fibrin degradation products in childhood acute nephritis.
    Dawson KP
    N Z Med J; 1977 Oct; 86(597):332-4. PubMed ID: 272538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Assay of GBM antigen in urine and serum with an anti-human renal monoclonal antibody].
    Mino Y
    Nihon Jinzo Gakkai Shi; 1990 Apr; 32(4):365-72. PubMed ID: 2376909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intraglomerular deposition of coagulation-fibrinolysis factors and a platelet membrane antigen in various glomerular diseases.
    Deguchi F; Tomura S; Yoshiyama N; Takeuchi J
    Nephron; 1989; 51(3):377-83. PubMed ID: 2563903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary fibrin and fibrinogen degradation products and the origin of hematuria.
    Tsukahara H; Hiraoka M; Sudo M; Okada T; Morikawa K; Kuroda M
    Acta Paediatr Jpn; 1992 Oct; 34(5):525-9. PubMed ID: 1442024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnostic significance of the demonstration of fibrin and fibrinogen degradation products in the urine].
    Bendel M; Oetliker O; Montandon A; Beck EA
    Schweiz Med Wochenschr; 1975 Aug; 105(33):1040-7. PubMed ID: 1099647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary fibrin/fibrinogen degradation product E (FDP-E) measured by a highly sensitive ELISA method in renal diseases.
    Shibata T; Magari Y; Mizunaga S; Ishii T; Tomo T; Yasumori R; Nasu M; Taguchi T
    Nephron; 1998 Aug; 79(4):494-5. PubMed ID: 9689177
    [No Abstract]   [Full Text] [Related]  

  • 34. [Origin of urinary FDP in children with renal diseases].
    Yoshioka K; Iseki T; Ikeda H; Akano N; Uraoka Y; Miyata H; Maki S
    Nihon Jinzo Gakkai Shi; 1982 Mar; 24(3):285-93. PubMed ID: 7120693
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical evaluation of a test for plasma fibrin/fibrinogen degradation products (FDP) based on monoclonal anti-FDP antibody technology: an application for the scoring system of the disseminated intravascular coagulation (DIC) diagnostic criteria].
    Ito K; Wada H; Abe Y; Tomatsu H; Nishioka J; Nobori T
    Rinsho Byori; 2003 Apr; 51(4):295-9. PubMed ID: 12747249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [False positive FDP test associated with malignant lymphoma].
    Kitazume K; Usuki K; Endo M; Osawa M; Iki S; Urabe A
    Rinsho Ketsueki; 1997 Jan; 38(1):52-7. PubMed ID: 9028162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urine fibrin degradation products in detection and management of acute and chronic renal transplant rejection.
    Cattran DC; Hockley M; Fenton SS; Wilson DR
    Clin Nephrol; 1977 Jun; 7(6):255-61. PubMed ID: 326454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of urinary fibrin-fibrinogen degradation products in kidney transplantation.
    Exaire E; Flores-Izquierdo G; Ortiz F; Pizzuto J; Cruz M; Gutiérrez ML
    Arch Invest Med (Mex); 1978; 9(3):503-10. PubMed ID: 361009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Urinary excretion of fibrin degradation products in children with nephrotic syndrome (author's transl)].
    Bouissou F; Barthe P; Boneu B
    Arch Fr Pediatr; 1980 Mar; 37(3):167-71. PubMed ID: 7469695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of latex agglutination tests for fibrin-fibrinogen degradation products in the forensic identification of menstrual blood.
    Akutsu T; Watanabe K; Motani H; Iwase H; Sakurada K
    Leg Med (Tokyo); 2012 Jan; 14(1):51-4. PubMed ID: 22189168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.